A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
2014 · Clinical Infectious Diseases · 221 citations
https://doi.org/10.1093/cid/ciu219
A
Andrés Sánchez‐Salinas
Orlando Health(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
132
Papers
1.3K
Citations
15
h-index
18
i10-index
Andrés Sánchez‐Salinas is an academic researcher from Orlando Health. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & CAR-T cell therapy research. The author has an h-index of 15, co-authored 113 publications.
ORCID: 0000-0001-9495-3555Papers by this author
worksSARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders
2022 · Journal of Hematology & Oncology · 38 citations
https://doi.org/10.1186/s13045-022-01275-7
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients
2023 · Blood Cancer Journal · 31 citations
https://doi.org/10.1038/s41408-022-00778-3
Spinal cord infarction: aetiology, imaging findings, and prognostic factors in a series of 41 patients
2021 · Neurología (English Edition) · 18 citations
https://doi.org/10.1016/j.nrleng.2020.11.004
Immunotherapy with CAR-T cells in paediatric haematology-oncology
2020 · Anales de Pediatría (English Edition) · 3 citations
https://doi.org/10.1016/j.anpede.2019.12.003
Prospective observational study of oral clonazepam to prevent high-dose busulfan-induced seizures in adult patients
2025 · Journal of the Egyptian National Cancer Institute · 1 citations
https://doi.org/10.1186/s43046-025-00257-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat